Clozapine induced eosinophilia.

Area of Science:

• Psychiatry
• Pharmacology
• Hematology

Background:

• Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia and other psychiatric conditions.
• While generally well-tolerated, clozapine is associated with various side effects requiring vigilant patient monitoring.
• Known side effects include sedation, sialorrhea, and weight gain; rare hematological abnormalities like eosinophilia have been reported.

Purpose of the Study:

• To report a rare case of clozapine-induced eosinophilia in a patient diagnosed with schizoaffective disorder.
• To describe the clinical course and resolution of eosinophilia during ongoing clozapine therapy.
• To contribute to the literature on clozapine's adverse effects, particularly in the context of schizoaffective disorder.

Main Methods:

• Case report detailing a patient with schizoaffective disorder undergoing clozapine treatment.
• Monitoring of peripheral blood eosinophil counts during the initial weeks of clozapine therapy.
• Observation of eosinophil levels following continued clozapine administration.

Main Results:

• The patient developed eosinophilia within the initial weeks of starting clozapine.
• Eosinophil counts gradually decreased to baseline levels with continued clozapine treatment over several weeks.
• No specific intervention was required to manage the eosinophilia beyond continued therapy.

Conclusions:

• Clozapine-induced eosinophilia can occur in patients with schizoaffective disorder.
• This adverse effect may be transient and resolve with continued clozapine treatment.
• This case may represent the first documented instance of clozapine-associated eosinophilia in schizoaffective disorder.